Results 91 to 100 of about 30,877 (270)
Journal of ArrhythmiaBackground The transdermal patch of bisoprolol available in Japan has been reported to demonstrate superior efficacy in preventing postoperative atrial fibrillation, possibly surpassing its oral counterpart.
Andrew G. Kim +7 more
doaj +1 more source
Российский кардиологический журнал, 2018 Aim. To compare the efficacy of combinational therapy with added bisoprolol or sotalol, in patients with ventricular rhythm disorders (VRD) via the assessment of regulatory-adaptive status (RAS).Material and methods. Sixty VRD patients with II-III Bigger
V. G. Tregubov +3 more
doaj +1 more source
Российский кардиологический журнал, 2020 Aim. To study the effect of ivabradine and bisoprolol on cardiac hemodynamics and diastolic remodeling in gout patients with coronary artery disease and hypertension and without left ventricular systolic dysfunction.Material and methods.
N. N. Kushnarenko +3 more
doaj +1 more source
PLoS ONE, 2023 BackgroundPatients with chronic obstructive pulmonary disease (COPD) often have exercise intolerance. The prevalence of hypertension in COPD patients ranges from 39-51%, and β-blockers and amlodipine are commonly used drugs for these patients ...
Chou-Chin Lan +6 more
doaj +1 more source
Should socioeconomic factors be considered as traditional risk factors for cardiovascular disease, as confounders, or as risk modifiers? [PDF]
, 2008 A large number of studies show that cardiovascular disease and its traditional risk factors are associated with socioeconomic conditions. However, their etiological role in the development of cardiovascular outcomes is not always well understood ...
De Vogli, R., Marmot, M.
core
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. [PDF]
, 2005 AIMS: We studied the influence of heart rate (HR), systolic blood pressure (SBP), and beta-blocker dose on outcome in the 2599 out of 3029 patients in Carvedilol Or Metoprolol European Trial (COMET) who were alive and on study drug at 4 months after ...
Charlesworth A +11 more
core +1 more source
Reduced Descending Itch Inhibition in Peripheral Neuropathy Patients With Chronic Pruritus
European Journal of Pain, Volume 30, Issue 1, January 2026.ABSTRACT Background Peripheral neuropathies (PNP) cause a wide range of symptoms of which pruritus and pain are a major burden to patients. Clarifying their mechanisms will facilitate the adequate symptom management. In contrast to neuropathic pain, neuropathic pruritus has long been understudied.
Jonas Eck +9 more
wiley +1 more source
Cardiac involvement in hereditary myopathy with early respiratory failure: A cohort study. [PDF]
, 2016 OBJECTIVE: To assess whether hereditary myopathy with early respiratory failure (HMERF) due to the c.951434T>C; (p.Cys31712Arg) TTN missense mutation also includes a cardiac phenotype.
Barresi, Rita +7 more
core +1 more source
Learning Health Systems, Volume 10, Issue 1, January 2026.ABSTRACT Introduction Despite strong evidence supporting guideline‐directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF), a significant gap persists in the consistent application of these therapies. This shortfall has prompted organizations like the American College of Cardiology to recommend leveraging electronic ...
Joey LeGrand +5 more
wiley +1 more source
Can atogepant be a preventive treatment for cluster headache?—Insights from a case series
Headache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 336-340, January 2026.Abstract Cluster headache (CH) is a disabling primary headache disorder with limited therapeutic options. Calcitonin gene‐related peptide (CGRP) is known to be involved in CH pathophysiology; however, except for galcanezumab (300 mg) in episodic CH, anti‐CGRP monoclonal antibodies did not reduce CH attacks in randomized clinical trials. Atogepant is an
Catarina Serrão +3 more
wiley +1 more source